Cargando…

Cytokine-Targeted Therapeutics for KSHV-Associated Disease

Kaposi’s sarcoma-associated herpesvirus (KSHV) also known as human herpesvirus 8 (HHV-8), is linked to several human malignancies including Kaposi sarcoma (KS), primary effusion lymphoma (PEL), multicentric Castleman’s disease (MCD) and recently KSHV inflammatory cytokine syndrome (KICS). As with ot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alomari, Nedaa, Totonchy, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600567/ https://www.ncbi.nlm.nih.gov/pubmed/32998419 http://dx.doi.org/10.3390/v12101097

Ejemplares similares

IL-21 signaling promotes the establishment of KSHV infection in human tonsil lymphocytes by increasing differentiation and targeting of plasma cells
por: Alomari, Nedaa, et al.
Publicado: (2022)

Host-Level Susceptibility and IRF1 Expression Influence the Ability of IFN-γ to Inhibit KSHV Infection in B Lymphocytes
por: Alomari, Nedaa, et al.
Publicado: (2022)

Molecular Virology of KSHV in the Lymphocyte Compartment—Insights From Patient Samples and De Novo Infection Models
por: Aalam, Farizeh, et al.
Publicado: (2020)

KSHV induces immunoglobulin rearrangements in mature B lymphocytes
por: Totonchy, Jennifer, et al.
Publicado: (2018)

Analysis of KSHV B lymphocyte lineage tropism in human tonsil reveals efficient infection of CD138+ plasma cells
por: Aalam, Farizeh, et al.
Publicado: (2020)

KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman’s disease
por: Polizzotto, Mark N, et al.
Publicado: (2010)

KSHV LANA—The Master Regulator of KSHV Latency
por: Uppal, Timsy, et al.
Publicado: (2014)

Suppression of DC-SIGN and gH Reveals Complex, Subset-Specific Mechanisms for KSHV Entry in Primary B Lymphocytes
por: Palmerin, Nancy, et al.
Publicado: (2021)

Chromatinization of the KSHV Genome During the KSHV Life Cycle
por: Uppal, Timsy, et al.
Publicado: (2015)

The Role of Bacteria in KSHV Infection and KSHV-Induced Cancers
por: Markazi, Ashley, et al.
Publicado: (2021)

Evidence for altered host genetic factors in KSHV infection and KSHV‐related disease development
por: Blumenthal, Melissa J., et al.
Publicado: (2020)

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2012)

KSHV and the Role of Notch Receptor Dysregulation in Disease Progression
por: DeCotiis, Jennifer L., et al.
Publicado: (2017)

Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection
por: Li, Tingting, et al.
Publicado: (2021)

Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2017)

SUMO and KSHV Replication
por: Chang, Pei-Ching, et al.
Publicado: (2014)

Emerging Themes from EBV and KSHV microRNA Targets
por: Ramalingam, Dhivya, et al.
Publicado: (2012)

KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
por: Coen, Natacha, et al.
Publicado: (2014)

Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma
por: Nayar, Utthara, et al.
Publicado: (2010)

KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi’s sarcoma
por: Cavallin, Lucas E, et al.
Publicado: (2010)

Characteristics of circulating KSHV-infected viroblasts during active KSHV(+) multicentric Castleman disease
por: Martin de Frémont, Gregoire, et al.
Publicado: (2022)

Regulation of KSHV Latency and Lytic Reactivation
por: Broussard, Grant, et al.
Publicado: (2020)

Molecular Biology of KSHV Lytic Reactivation
por: Purushothaman, Pravinkumar, et al.
Publicado: (2015)

KSHV-Mediated Angiogenesis in Tumor Progression
por: Purushothaman, Pravinkumar, et al.
Publicado: (2016)

Towards Understanding KSHV Fusion and Entry
por: Dollery, Stephen J.
Publicado: (2019)

Cellular Receptors Involved in KSHV Infection
por: van der Meulen, Emma, et al.
Publicado: (2021)

Echinomycin as a promising therapeutic agent against KSHV-related malignancies
por: Chen, Jungang, et al.
Publicado: (2023)

Cytokines as therapeutic targets for cardio- and cerebrovascular diseases
por: Liberale, Luca, et al.
Publicado: (2021)

Contribution of Viral Mimics of Cellular Genes to KSHV Infection and Disease
por: Sakakibara, Shuhei, et al.
Publicado: (2014)

Role of Pattern Recognition Receptors in KSHV Infection
por: Uppal, Timsy, et al.
Publicado: (2018)

Twenty Years of KSHV
por: Chang, Yuan, et al.
Publicado: (2014)

Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
por: Bhatt, A, et al.
Publicado: (2009)

Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors
por: Tolani, Bhairavi, et al.
Publicado: (2013)

KSHV ORF57, a Protein of Many Faces
por: Majerciak, Vladimir, et al.
Publicado: (2015)

Co-infections and Pathogenesis of KSHV-Associated Malignancies
por: Thakker, Suhani, et al.
Publicado: (2016)

KSHV Entry and Trafficking in Target Cells—Hijacking of Cell Signal Pathways, Actin and Membrane Dynamics
por: Kumar, Binod, et al.
Publicado: (2016)

Next-Generation Sequencing in the Understanding of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Biology
por: Strahan, Roxanne, et al.
Publicado: (2016)

Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV
por: Gam ze Letova, Chen, et al.
Publicado: (2021)

Identification of Cellular Genes Targeted by KSHV-Encoded MicroRNAs
por: Samols, Mark A, et al.
Publicado: (2007)

Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia
por: Velasco, P, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7gpqn2g1fn5nacreddvld0gr1s